Skip to main content
Evelyn, a child with SMA, riding a bike as her parents, Elena and Milan, walk by her side

The path to treatment with ZOLGENSMA

Evelyn has 2 copies of SMN2 gene
Treated at ~2 months old
 

Take these next steps for your child

Early diagnosis and early treatment can help stop the progression of spinal muscular atrophy (SMA).* When that treatment is ZOLGENSMA® (onasemnogene abeparvovec-xioi), we’ll be there with you through every step of your treatment journey to help ensure the process goes smoothly. Here’s what you can expect:

Icon of a microscope

Important lab tests

Your child’s doctor will schedule lab tests to help determine eligibility for your child. It’s generally best to have the tests done as soon as you can so that your child can get treated as quickly as possible; work with your doctor to schedule them.

Icon of an Rx form

Your child’s doctor submits Prescription and Start Forms

While waiting for the results of your child’s lab tests, ask their doctor to submit two forms: a Prescription Form and a Start Form to enroll you in Novartis Patient SupportTM, which provides additional support before, during, and after treatment.

Icon of insurance cards

Working with your insurance

Your Novartis Patient Support team can help with the verifications and authorizations required for treatment.

Icon of a checklist

Preparing for treatment day

To make the day go smoothly, confirm the logistics, ensure all blood work has been completed, watch for signs of infection, and start the prescribed corticosteroid. And, schedule follow-up appointments with your child’s doctor.

Icon of a strand of DNA with a green checkmark

Treatment Day!

Administer a second corticosteroid dose, and confirm follow-up appointments. Expect the infusion to take about 60 minutes. You will be asked to remain at the treatment center for a period of time after treatment. Ask your doctor in advance how long you’ll be required to stay.

Icon of a person holding a child

Moving forward after SMA treatment

Immediately after infusion

 

You and your child’s doctor will schedule a number of follow-up appointments over the next 3 months or longer for follow-up lab work.

What to watch for after your child’s infusion with ZOLGENSMA® (onasemnogene abeparvovec-xioi).

Your Care Plan After Treatment

Looking to the future

Your Novartis Patient Support team will reach out to follow up. To help meet your long-term goals, speak with your child’s neuromuscular specialist, and maintain check-ups.

If you still have questions about what to expect next, please reach out to your doctor.

*Results and outcomes vary among children based on several factors, including how far their SMA symptoms progressed prior to receiving treatment.

Not a member of Novartis Patient Support?

A step-by-step guide to one-time ZOLGENSMA treatment.

Want to know more?

Download our Step-by-Step Guide to treatment with ZOLGENSMA

Learn about other families’ experiences with ZOLGENSMA